CYP3A4 and CYP1A2 have been shown to be efficient in metabolizing aflatoxin B1 (AFB1), a carcinogen implicated in the etiology of hepatocellular carcinoma (HCC) [84]. Here, CYP3A4 is linked to hepatocellular carcinoma.